| ABIRATERONE |
Zytiga® |
Janssen-Cilag Pty Ltd |
Castration resistant carcinoma of the prostate |
Jul 2021 |
|
| ACALABRUTINIB |
Calquence® |
AstraZeneca Pty Ltd |
Relapsed and/or refractory mantle cell lymphoma (R/R MCL) |
Jul 2021 |
|
| ADALIMUMAB |
Abrilada® |
Pfizer Australia Pty Ltd |
Severe Crohn disease; Moderate to severe ulcerative colitis; Severe active juvenile
idiopathic arthritis; Complex refractory fistulising Crohn disease; Severe active
rheumatoid arthritis; Severe psoriatic arthritis; Ankylosing spondylitis; Severe chronic
plaque psoriasis; Moderate to severe hidradenitis suppurativa. |
Jul 2021 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT METHIONINE |
HCU express 15® |
Vitaflo Australia Pty Limited |
Pyridoxine non-responsive homocystinuria |
Jul 2021 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE |
PKU express 15® |
Vitaflo Australia Pty Limited |
Phenylketonuria |
Jul 2021 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE |
PKU express 20® |
Vitaflo Australia Pty Limited |
Phenylketonuria |
Jul 2021 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE AND TYROSINE |
TYR Express 15® |
Vitaflo Australia Pty Limited |
Tyrosinaemia |
Jul 2021 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE AND ISOLEUCINE |
MSUD express 15® |
Vitaflo Australia Pty Limited |
Maple syrup urine disease |
Jul 2021 |
|
| BARICITINIB |
Olumiant® |
Eli Lilly Australia Pty Ltd |
Severe atopic dermatitis |
Jul 2021 |
|
| BORTEZOMIB |
Bortezomib Juno® |
Juno Pharmaceuticals Pty Ltd |
Multiple Myeloma |
Jul 2021 |
|
| BORTEZOMIB |
DBL Bortezomib® |
Pfizer Australia Pty Ltd |
Multiple Myeloma |
Jul 2021 |
|
| BUDESONIDE + GLYCOPYRRONIUM + FORMOTEROL |
Breztri Aerosphere® |
AstraZeneca Pty Ltd |
Moderate to severe chronic obstructive pulmonary disease (COPD) |
Jul 2021 |
|
| DAPAGLIFLOZIN |
Forxiga® |
AstraZeneca Pty Ltd |
Heart failure |
Jul 2021 |
|
| DAPAGLIFLOZIN |
Forxiga® |
AstraZeneca Pty Ltd |
Chronic kidney disease |
Jul 2021 |
|
| DARATUMUMAB |
Darzalex® |
Janssen-Cilag Pty Ltd |
Relapsed and/or refractory multiple myeloma (RRMM) |
Jul 2021 |
|
| DAROLUTAMIDE |
Nubeqa® |
Bayer Australia Ltd |
Castration resistant carcinoma of the prostate |
Jul 2021 |
|
| DECITABINE WITH CEDAZURIDINE |
Inqovi® |
Otsuka Australia Pharmaceutical Pty. Ltd |
High risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) |
Jul 2021 |
|
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR |
Trikafta® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
Cystic fibrosis |
Jul 2021 |
|
| ELOTUZUMAB |
Empliciti® |
Bristol-Myers Squibb Australia Pty Ltd |
Relapsed and/or refractory multiple myeloma (RRMM) |
Jul 2021 |
|
| ENZALUTAMIDE |
Xtandi® |
Astellas Pharma Australia Pty Ltd |
Castration resistant carcinoma of the prostate |
Jul 2021 |
|
| ESKETAMINE |
Spravato® |
Janssen-Cilag Pty Ltd |
Treatment resistant depression |
Jul 2021 |
|
| ETANERCEPT |
Enbrel® |
Pfizer Australia Pty Ltd |
Rheumatoid arthritis; Plaque psoriasis; Ankylosing spondylitis; Psoriatic arthritis;
Juvenile idiopathic arthritis; Paediatric plaque psoriasis. |
Jul 2021 |
|
| FOLLITROPIN ALFA |
Ovaleap® |
Theramex Australia Pty Ltd |
Assisted Reproductive Technology; Anovulatory infertility; Infertility. |
Jul 2021 |
|
| HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND
CARBOHYDRATE |
KetoVie Peptide 4:1 |
Cortex Health Pty Ltd |
Ketogenic diet |
Jul 2021 |
|
| HYDROCORTISONE |
Alkindi® |
Chiesi Australia Pty Ltd |
Adrenal Insufficiency |
Jul 2021 |
|
| HYPROMELLOSE |
Revive Tears® |
Petrus Pharmaceuticals Pty Ltd |
Severe dry eye syndrome, including Sjogren's syndrome |
Jul 2021 |
|
| LANADELUMAB |
Takhzyro® |
Takeda Pharmaceuticals Australia Pty. Ltd. |
Hereditary angioedema |
Jul 2021 |
|
| LORLATINIB |
Lorviqua® |
Pfizer Australia Pty Ltd |
Locally advanced (stage IIIB) or metastatic (stage IV) anaplastic lymphoma kinase
(ALK)-positive non-small cell lung cancer (NSCLC) |
Jul 2021 |
|
| LUMACAFTOR + IVACAFTOR |
Orkambi® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
Cystic fibrosis |
Jul 2021 |
|
| MELATONIN |
Slenyto® |
Aspen Pharmacare Australia Pty Limited |
Insomnia |
Jul 2021 |
|
| METHOXSALEN |
Uvadex® |
Terumo BCT Australia Pty Limited |
Steroid dependent or steroid intolerant or steroid refractory chronic graft versus
host disease (cGVHD) |
Jul 2021 |
|
| NIRAPARIB |
Zejula® |
GlaxoSmithKline Australia Pty Ltd |
High grade epithelial ovarian, fallopian tube, or primary peritoneal cancer |
Jul 2021 |
|
| NIVOLUMAB |
Opdivo® |
Bristol-Myers Squibb Australia Pty Ltd |
Second-line squamous cell oesophageal carcinoma (2L OSCC) |
Jul 2021 |
|
| NUSINERSEN |
Spinraza® |
Biogen Australia Pty Ltd |
Spinal muscular atrophy (SMA) |
Jul 2021 |
|
| OPICAPONE |
Ongentys® |
MAXX PHARMA PTY LTD |
Parkinson Disease (PD) |
Jul 2021 |
|
| PALBOCICLIB |
Ibrance® |
Pfizer Australia Pty Ltd |
Hormone receptor-positive (HR+), human epidermal growth factor receptor-2 negative
(HER2-) advanced or metastatic breast cancer |
Jul 2021 |
|
| RAVULIZUMAB |
Ultomiris® |
Alexion Pharmaceuticals Australasia Pty Ltd |
Paroxysmal nocturnal haemoglobinuria (PNH) |
Jul 2021 |
|
| RIPRETINIB |
Qinlock® |
Specialised Therapeutics Pm Pty Ltd |
Gastrointestinal stromal tumour |
Jul 2021 |
|
| SECUKINUMAB |
Cosentyx® |
Novartis Pharmaceuticals Australia Pty Limited |
Ankylosing spondylitis |
Jul 2021 |
|
| SELINEXOR |
Xpovio® |
Antengene (Aus) Pty. Ltd. |
Triple class refractory/penta-refractory multiple myeloma (TCR/PR MM) |
Jul 2021 |
|
| SELINEXOR |
Xpovio® |
Antengene (Aus) Pty. Ltd. |
Relapsed and/or refractory diffuse large B-cell lymphoma (DLBCL) |
Jul 2021 |
|
| SELINEXOR |
Xpovio® |
Antengene (Aus) Pty. Ltd. |
Relapsed and/or refractory multiple myeloma |
Jul 2021 |
|
| SILTUXIMAB |
Sylvant® |
Eusa Pharma (UK) Ltd |
Idiopathic multicentric Castleman’s disease (iMCD) |
Jul 2021 |
|
| TRABECTEDIN |
Yondelis® |
Specialised Therapeutics Pharma Pty Ltd |
Advanced (unresectable and/or metastatic) leiomyosarcoma |
Jul 2021 |
|
| TRIPTORELIN |
Diphereline® |
Ipsen Pty Ltd |
Central precocious puberty (CPP) |
Jul 2021 |
|
| UPADACITINIB |
Rinvoq® |
AbbVie Pty Ltd |
Severe atopic dermatitis |
Jul 2021 |
|
| VENETOCLAX |
Venclexta® |
AbbVie Pty Ltd |
Acute myeloid leukaemia |
Jul 2021 |
|
| ZANUBRUTINIB |
Brukinsa® |
BeiGene Aus Pty Ltd |
Waldenstrom macroglobulinemia |
Jul 2021 |
|
| ZANUBRUTINIB |
Brukinsa® |
BeiGene Aus Pty Ltd |
Relapsed and/or refractory mantle cell lymphoma |
Jul 2021 |
|